| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kalvista Pharmaceuticals, Inc. (KALV) has 12 insiders with recent SEC Form 4 filings, including 8 buys and 8 sells. KALV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 462.6K | $12.49M | - | |
| Other | 223.5K | $6.03M | - | |
| Other | 142.5K | $3.85M | - | |
| Other | 100.0K | $2.70M | - | |
| Other | 51.4K | $1.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2024 | Venrock Healthcare Capital Partners Iii, L.P.54 | 10% Owner | Buy | 137,700 | $12.54 | $1,726,456.92 | +1.1% | -7.1% | -38.2% | |
| Jan 9, 2024 | Feener Edward P.72 | Chief Scientific Officer | Sell | 17,321 | $13.01 | $225,300.44 | -12.2% | -13.5% | -35.5% | |
| Jan 4, 2024 | Venrock Healthcare Capital Partners Iii, L.P.54 | 10% Owner | Buy | 59,369 | $12.14 | $720,543.04 | +0.7% | -4.0% | -23.0% | |
| Dec 29, 2023 | Venrock Healthcare Capital Partners Iii, L.P.54 | 10% Owner | Buy | 519,017 | $12.46 | $6,465,649.95 | +4.6% | -3.2% | -30.4% | |
| Dec 27, 2023 | Crockett Thomas Andrew72 | CEO | Sell | 30,000 | $12.02 | $360,453.00 | -19.0% | -7.7% | -26.7% | |
| Nov 20, 2023 | Audhya Paul K. | Chief Medical Officer | Sale+OE | 7,985 | $8.23 | $65,710.96 | -17.9% | +68.1% | +10.2% | |
| Nov 20, 2023 | Feener Edward P.72 | Chief Scientific Officer | Sale+OE | 4,958 | $8.23 | $40,800.87 | -5.8% | +68.1% | +10.2% | |
| Nov 20, 2023 | Yea Christopher53 | Chief Development Officer | Sale+OE | 7,113 | $8.23 | $58,535.01 | -13.4% | +68.1% | +10.2% | |
| Nov 20, 2023 | Palleiko Benjamin L46 | President, CFO, Cbo &Sec'y | Sale+OE | 13,008 | $8.23 | $107,046.73 | -10.4% | +68.1% | +10.2% | |
| Nov 20, 2023 | Crockett Thomas Andrew72 | CEO | Sale+OE | 14,807 | $8.23 | $121,851.25 | -8.6% | +68.1% | +10.2% |